medigraphic.com
Instituto Nacional de Salud Pública

2010, Number 6

<< Back Next >>

salud publica mex 2010; 52 (6)

Estimating the cost of treating patients with liver cirrhosis at the Mexican Social Security Institute

María Esther Quiroz, Yvonne N Flores, Belkis Aracena, Víctor Granados-García V, Salmerón J, Pérez R, Cabrera G, Bastani R

Language: English
References: 41
Page: 493-501
PDF size: 139.26 Kb.


ABSTRACT

Objective. To estimate the annual cost of treating patients with cirrhosis at the Mexican Institute of Social Security (IMSS per its abbreviation in Spanish). Material and Methods. The annual cost of treating three stages of cirrhosis (Child- Pugh A, Child-Pugh B and Child-Pugh C) was estimated using micro-costing techniques and medical experts. These results were compared and contrasted with prices reported by IMSS. Results. The annual cost of treatment, in USA dollars, by Child- Pugh stage was: a) micro-costing results: $1 110.17 stage A, $549.55 stage B and $348.16 stage C; b) opinion of medical experts: $1 633.64, $6 564.04 and $19 660.35, respectively; and c) IMSS costs: $4 269.00, $16 949.63 and $30 249.25, respectively. Conclusions. The cost of treating patients with cirrhosis is considerable, and costs increase as the disease worsens. Cost estimates vary depending on the source of information, and the methodology used. There are discrepancies between the procedures reported in medical records and treatment recommendations by IMSS liver experts.


REFERENCES

  1. Sistema Nacional de Información en Salud (SINAIS). Principales causas de mortalidad general, 2005. [monografía en Internet]. México: SSA, 2005. [Consulted June 2010]. Available at: http://sinais.salud.gob.mx/ descargas/xls/m_005.xls

  2. Sistema Nacional de Información en Salud (SINAIS). Principales causas de mortalidad en edad productiva (de 15 a 64 años), 2005. [online monograph]. Mexico: SSA, 2005. [Consulted June 2010]. Available at: http:// sinais.salud.gob.mx/descargas/xls/m_009.xls

  3. Instituto Nacional de Estadística, Geografía e Informática. Defunciones generales por principales causas de mortalidad, 2007. [online monograph]. Mexico: INEGI, 2007. [Consulted June 2010]. Available at: http:// www.inegi.org.mx/est/contenidos/espanol/soc/sis/sisept/default. aspx?t=mpob107&c=14742&e=

  4. Sistema Nacional de Información en Salud (SINAIS). Diez principales causas de mortalidad en mujeres. 2007. [online monograph]. Mexico: SSA, 2007. [Consulted June 2010]. Available at: http://sinais.salud.gob.mx/ descargas/xls/diezprincausasmort2007_CNEGySR.xls

  5. Schuppan D, Afdhal NH. Liver cirrhosis. Lancet 2008;371(9615):838-851.

  6. D’Amico G, Garcia G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studies. Journal Hepatol 2006;44:217-231.

  7. Tierney LM, McPhee SJ, Papadakis MA. Liver biliary tract and pancreas. In: Current medical diagnosis and treatment. 43rd. edition. United States: McGraw Hill, 2004:623-668.

  8. Child CG, Turcotte JG. Surgery and portal hypertension. In: The liver and portal hypertension. Philadelphia: Saunders, 1964:50-58.

  9. Talwalkar J, Kamath P. Influence of recent advances in medical management on clinical outcomes of cirrhosis. Mayo Clin Proc 2005;80(11):1501-1508.

  10. Instituto Mexicano del Seguro Social. Información estadística en Salud. Total Nacional Enero a Octubre Del 2009. [online monograph]. Mexico: IMSS, 2009. [Consulted June 2010]. Available at: http://www.imss.gob.mx/dpm/dis/Tabla.aspx?Srv=M00- 1&ID=SCES006_001_001&OPC=opc03

  11. Reynales-Shigematsu LM, Rodríguez-Bolaños Rde L, Jiménez JA, Juárez-Márquez SA, Castro-Ríos A, Hernández-Avila M. Health care costs attributable to tobacco consumption on a national level in the Mexican Social Security Institute. Salud Publica Mex 2006;48 Suppl 1:S48-S64.

  12. Drummond MF, Sculpher M J, Torrance G W, O’Brien B J, Stoddart GL. Methods for the economic evaluation of health care programmes, 3rd edition. New York: Oxford University Press, 2005.

  13. Drummond M F, Brandt A, Luce B, Rovira J. Standardizing methodologies for economic evaluation in health care. In: Practice, problems, and potential. Int J Technol Assess Health Care 1993;9(1):26-36.

  14. Tan S, Rutten F, Ineveld B, Redekop W. Comparing methodologies for the cost estimation of hospital services. Eur J Health Ecom 2009;10:39-45.

  15. 15.Arredondo A, Damián T. Costos económicos en la producción de los servicios de salud: del costo de los insumos al costo de manejo de caso. Salud Publica Mex 1997;39:117-124.

  16. Arredondo A. Los niveles de aproximación conceptual. In: Economía de la salud para América Latina. Lima, Perú: University of San Marco, 1999:33-40.

  17. Banco de México (Banxico). Calculadora de inflación, 2010. [monografía en Internet]. Mexico: Banco de México, 2010. [Consulted June 2010]. Available at: http://www.banxico.org.mx/polmoneinflacion/ servicios/calcDeInflacion/calcDeInflac.html

  18. Banco de México (Banxico). Tipos de cambio y resultados históricos de las subastas, 2010. [monografía en Internet]. México: Banco de México, 2010. [Consulted June 2010]. Available at: http://www.banxico.org.mx/ PortalesEspecializados/tiposCambio/indicadores.html

  19. Practice Guidelines. Proposed recommendations for the American College of Gastroenterology. Am J Gastroenterol 1998;93:2022-2024.

  20. American Association of the Study of Liver Disease. Position paper: Practice Guidelines. Hepatology 2005;41(5): 2005.

  21. Aracena B, Gutierrez JP, Bertozzi SM, Gertler P. Cost of AIDS care in Mexico: What are its main individual predictors? Arch Med Res 2005;36(5):560-566.

  22. Bautista S, Dmytraczenko T, Kombe G, Bertozzi SM. Costos del tratamiento de VIH/SIDA en México. Salud Publica Mex 2008;50(4):S437-S444.

  23. Creese A, Parker D. Organización Mundial de la Salud, Fondo de las Naciones Unidas para la Infancia. Cost analysis in primary health care. Geneva:WHO, 1994:5-9.

  24. Reedy D, Loo A, Levine R. AST/ALT Ratio 􀀪1 Is not diagnostic of cirrhosis in patients with chronic hepatitis C. Dig Dis Sci 1998;43: 2156-2159.

  25. Calès P, Boursier J, Oberti F. Ultrasonographic elastometry vs. blood tests for the diagnosis of cirrhosis. J Hepatol 2009;51(1):228-229.

  26. Manning DS, Afdhal NH. Diagnosis and quantitation of fibrosis. Gastroenterology 2008;134(6):1670-1681.

  27. Drummond MF, Stoddart GL, Torrance GW. Métodos para la evaluación económica de los Programas de Atención a la Salud. 2nd edition. Madrid: Ediciones Díaz de Santos, 2001.

  28. Catálogo Delegacional de Consumibles. Emitido por la Coordinación de Abastecimiento y Equipamiento de la Delegación Morelos IMSS. Mexico: Instituto Mexicano del Seguro Social, 2006.

  29. Catálogo Delegacional de Recursos Humanos. Subdirección General de Recursos Humanos. Mexico: Instituto Mexicano del Seguro Social, 2006.

  30. Catálogo Delegacional de Bienes Inmuebles. Subdirección General de Obras y Patrimonio Inmobiliario. Mexico: Instituto Mexicano del Seguro Social, 2006.

  31. Knaul FM, Arreola-Ornelas H, Velázquez E, Dorantes J, Méndez O, Avila-Burgos L. The health care costs of breast cancer: the case of the Mexican Social Security Institute. Salud Pub Mex 2009;51 Suppl 2:S286-S295.

  32. Mould-Quevedo JF, García-Peña C, Contreras-Hernández I, Juárez-Cedillo T, Espinel-Bermúdez C, Morales-Cisneros G, et al. Direct costs associated with the appropriateness of hospital stay in elderly population. BMC Health Serv Res 2009;22(9):151.

  33. Granados-García V, Velázquez-Castillo R, Garduño-Espinosa J, Torres- López J, Muñoz-Hernández O. Resource utilization and costs of treating severe rotavirus diarrhea in young Mexican children from the health care provider perspective. Rev Invest Clin 2009;61(1):18-25

  34. Villarreal-Ríos E, Mathew-Quiroz A, Garza-Elizondo ME, Núñez-Rocha G, Salinas-Martínez AM, Gallegos-Handal M. Cost of care of arterial hypertension and its impact on the budget assigned to health in Mexico. Salud Pub Mex 2002;44(1):7-13.

  35. Velasco-Murillo V, Navarrete-Hernández E, Pozos-Cavanzo JL, Ojeda-Mijares RI, Camacho-Rodríguez ML. Fractures in postmenopausal women in the IMSS: frequency and costs of hospital care. Gac Med Mex 2003;139(5):453-458.

  36. Muñoz-Carlin ML, Nevárez-Sida A, García-Contreras F, Mendieta- Sevilla SR, Constantino-Casas P. Cost-effectiveness of the treatment of acute and chronic rhinosinusitis at IMSS. Rev Invest Clin 2007;59(3): 197-205.

  37. Garcia-Tsao G, Lim JK. Management and treatment of patients with cirrhosis and portal hypertension: recommendations from the Department of Veterans Affairs Hepatitis C Resource Center Program and the National Hepatitis C Program. Am J Gastroenterol 2009;104(7):1802-1829.

  38. D’Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol 2006;44(1):217-231. 39. Gupte P, Amarapurkar D, Agal S. Non-alcoholic steatohepatitis in type 2 diabetes mellitus. J Gastroenterol Hepatol 2004;19(8):854-858.

  39. El-Serag HB, Tran T, Everhart JE. Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma. Gastroenterology 2004;126:460-468.

  40. Davila JA, Morgan RO, Shaib Y. Diabetes increases the risk of hepatocellular carcinoma in the United States: a population based case control study. Gut 2005;54(4):533-539.

  41. Flores Y, Yee HF, Leng M, Escarce J, Bastani R, Salmerón J, et al. Risk factors for chronic liver disease in Blacks, Mexican Americans, and Whites in the United States: Results From NHANES IV, 1999-2004. Am J Gastroenterol 2008;103(9):2231-2238.




2020     |     www.medigraphic.com